gvtcx

Commercial Services Relating to Recombinant Antibody Discovery and Antigen Generation

Defence Science and Technology Laboratory Published 15 Dec 2021 Contracts Finder

key details

Value£130,400
Statuscomplete
Category (CPV) 73111000
Deadline11 Nov 2021
Contract start18 Nov 2021
Contract end31 Mar 2022
Proceduredirect
SME suitableNo
OCIDocds-b5fd17-c1e6c446-df85-44f3-86f6-16a44fd944b4

Award

SupplierValueDateStatus
MOLOGIC LTD. £130,700 18 Nov 2021 active

description

Dstl has a requirement to access commercially available services related to antibody display library generation and antigen generation.

The Authority (Dstl) operates a mature programme of hybridoma-based antibody discovery and characterisation and is rapidly maturing a recombinant antibody-based approach to replace or augment the current approach. There are a number of drivers in place that promote delivering many of the aspects of this programme within Industry whilst retaining safety and security limited steps, as well as activities that maintain intelligent customer status, within Dstl.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
15 Dec 2021 Award (award) · c4c5f23f-5c74-456b-8b2f-cf34c83f7836-494105

more from Defence Science and Technology Laboratory

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.